Jun 19, 2018
Reinvigorated Healthcare Industry Being Boosted by Quantitative Advancements and Device Breakthroughs
Jun 06, 2018
Western European Cardiac Troponin Diagnostics Market to 2021
Mar 21, 2018
Study shows cardiac troponin measurement using ultra-sensitive Singulex cTnI test can identify the presence and severity of coronary artery disease in stable, symptomatic outpatients
Mar 13, 2018
Study adds to understanding about utility of ultra-sensitive cardiac troponin measurement in diagnosing and predicting cardiovascular syndromes
Feb 28, 2018
Study shows high-sensitivity cardiac troponin I concentration, measured with the Singulex cTnI assay, is an independent predictor of obstructive coronary artery disease in patients with suspected stable angina
Nov 01, 2017
Singulex announces 510(k) submission for the first ultra-sensitive cardiac troponin I (cTnI) test using Single Molecule Counting technology
Sep 08, 2017
Singulex Receives New, Broad Patent For Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out
Aug 14, 2017
World Cardiac Marker Analyzer Product Analysis, Cardiac Marker Companies Business & Marketing Strategy Research Report 2017
Aug 08, 2017
Cardiac Maker Analyzer Product Analysis: Comprehensive Analysis of the Cardiac Markers Analyzer Segments
Aug 01, 2017
Evaluations of the Analytical Performance of the Singulex Cardiac Troponin I Assay Used on its Single Molecule Counting Technology Platform Demonstrates Ability to Improve Cardiovascular Disease Rule-Out
Jun 01, 2017
First ultra-sensitive cardiac troponin (cTnI) test using Single Molecule Counting technology receives CE Mark